MAESTRO Study: Metabolic Imaging to Improve Patient-Specific Therapy Outcomes

Participants will undergo multiple 7T MR imaging sessions which include advanced 31P MRSI techniques, before start of palliative chemotherapy and during treatment until progression of disease or until week 54.